{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:37:11Z","timestamp":1791160631121,"version":"4.1.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/01.aids.0000327510.68503.e8","type":"journal-article","created":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T03:11:00Z","timestamp":1223521860000},"page":"S7-S12","source":"Crossref","is-referenced-by-count":121,"title":["HIV epidemiology and the effects of antiviral therapy on long-term consequences"],"prefix":"10.1097","volume":"22","author":[{"given":"Thomas C","family":"Quinn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-2-20210130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00002030-200101260-00002","article-title":"Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa","volume":"15","author":"Mukadi","year":"2001","journal-title":"AIDS"},{"key":"R3-2-20210130","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(06)69573-1","article-title":"Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa","volume":"368","author":"Gandhi","year":"2006","journal-title":"Lancet"},{"key":"R7-2-20210130","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.qai.0000179459.31562.16","article-title":"Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras","volume":"41","author":"Crum","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-2-20210130","first-page":"CD003510","article-title":"Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.","volume":"1","author":"Volmink","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-2-20210130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(06)68337-2","article-title":"Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries","volume":"367","author":"Braitstein","year":"2006","journal-title":"Lancet"},{"key":"R14-2-20210130","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/jama.296.6.679","article-title":"Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis","volume":"296","author":"Mills","year":"2006","journal-title":"JAMA"},{"key":"R15-2-20210130","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/QAD.0b013e32802e6bfa","article-title":"Treatment interruptions predict resistance in HIV-positive individuals purchasing fixed-dose combination antiretroviral therapy in Kampala, Uganda","volume":"21","author":"Oyugi","year":"2007","journal-title":"AIDS"},{"key":"R16-2-20210130","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/00002030-200309050-00011","article-title":"High levels of adherence do not prevent accumulation of HIV drug resistance mutations","volume":"17","author":"Bangsberg","year":"2003","journal-title":"AIDS"},{"key":"R17-2-20210130","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/jac\/dkh162","article-title":"Paradoxes of adherence and drug resistance to HIV antiretroviral therapy","volume":"53","author":"Bangsberg","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"R18-2-20210130","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/bmj.328.7434.280","article-title":"Antiretroviral therapy in Africa","volume":"328","author":"Stevens","year":"2004","journal-title":"BMJ"},{"key":"R19-2-20210130","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)60313-4","article-title":"Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial","volume":"369","author":"Gray","year":"2007","journal-title":"Lancet"},{"key":"R20-2-20210130","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(07)60312-2","article-title":"Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial","volume":"369","author":"Bailey","year":"2007","journal-title":"Lancet"},{"key":"R21-2-20210130","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0020298","article-title":"Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial","volume":"2","author":"Auvert","year":"2005","journal-title":"PLoS Med"},{"key":"R23-2-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200809003-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T22:23:59Z","timestamp":1618266239000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200809003-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":14,"journal-issue":{"issue":"Suppl 3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/01.aids.0000327510.68503.e8","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}